The global Optimize PRO study shows that using a standardized TAVR care pathway and cusp overlap technique with Evolut PRO/PRO+ valves led to low pacemaker rates, no moderate/severe aortic regurgitation, and favorable 30-day outcomes. SCAI Experts, Drs. Suzanne Baron, Steven Yakubov, John Forrest, and Mayra Guerrero discuss the highlights from this original research article.

Read the JSCAI article: https://doi.org/10.1016/j.jscai.2025.103515